XNAS · BCTX
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Briacell Therapeutics Corp. Common Shares

Briacell Therapeutics Corp. Common Shares

PHARMACEUTICAL PREPARATIONS
$4.07
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Analyst data unavailable at compute time
BCTX
Briacell Therapeutics Corp. Common Shares
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BCTX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BCTX catalysts
About Briacell Therapeutics Corp. Common Shares
PHARMACEUTICAL PREPARATIONS
Listed since
2023
Employees
4
Country
US

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.07
Last session
Day high
$4.07
Last session
Day low
$4.07
Last session
Previous close
$4.07
52W high
$13.79
-70.49% from high
52W low
$2.74
12% of range
Market cap
$35.4M
EPS
$-9.5600
Beta
1.68
Shares out
8.7M
Avg volume
114.4K
VWAP
$4.07
Last session
Price history computed in-house
1W
+20.06%
1M
+13.69%
3M
+19.01%
1Y
-41.68%
YTD
-42.76%
SMA 50 $3.43 · above
SMA 200 $5.12 · below
52W position 12%

BCTX overview

Veridion Score
59
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around BCTX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading BCTX Form 4 filings
Public disclosures

Congress activity in BCTX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for BCTX in the cached public ledger.

Federal contracts

BCTX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BCTX in this window.
Lobbying spend

BCTX lobbying filings, year to date.

Registered lobbying filings matched to Briacell Therapeutics Corp. Common Shares.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BCTX in this window.
Loading news for BCTX
Analyst ratings
Sovereign unlock shows live analyst consensus for BCTX.
Options
Sovereign unlock shows live options positioning for BCTX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.